Springer

SHERPA: Unknown

People

  1. Do
    Do
  2. Gollub
    Gollub
  3. Gonen
    Gonen
  4. Jarnagin
    Jarnagin
  5. Hricak
    Hricak
  6. D'Angelica
    D'Angelica
  7. Petkovska
    Petkovska
  8. Golia Pernicka
    Golia Pernicka
  9. Akin
    Akin
  10. Kingham
    Kingham

Groups

  1. Body Imaging Service (359)
  2. Radiology, Department of (359)
  3. Surgery (100)
  4. Molecular Imaging and Therapy Service (96)
  5. Epidemiology and Biostatistics (93)
  6. Biostatistics Service (82)
  7. Center for Pancreatic Cancer Research (76)
  8. Department of Medicine (70)
  9. Sloan Kettering Institute Postdocs (69)
  10. GSK Faculty (63)
Search Within
  1. "Body Imaging Service"
Formats
  1. Journal Article (235)
  2. Review (43)
  3. Book Section (34)
  4. Meeting Abstract (20)
  5. Conference Paper (11)
  6. Guidelines (7)
  7. Miscellaneous (7)
  8. Editorial (2)
Groups
  1. Body Imaging Service (359)
  2. Radiology, Department of (359)
  3. Surgery (100)
  4. Molecular Imaging and Therapy Service (96)
  5. Epidemiology and Biostatistics (93)
  6. Biostatistics Service (82)

More Groups

People
  1. Kinh Gian Do (56)
  2. Marc Gollub (47)
  3. Mithat Gonen (41)
  4. Hebert Vargas Alvarez (35)
  5. William Jarnagin (35)
  6. Hedvig Hricak (34)

More People

Years
  1. 2025 (13)
  2. 2024 (25)
  3. 2023 (34)
  4. 2022 (33)
  5. 2021 (38)
  6. 2020 (21)

More Years

Publications
  1. Abdominal Radiology (84)
  2. European Radiology (67)
  3. Annals of Surgical Oncology (39)
  4. European Journal of Nuclear Medicine and Molecular Imaging (18)
  5. Investigational New Drugs (18)
  6. Encyclopedia of Radiation Oncology (14)

More Publications

Results (359)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase I study of obatoclax mesylate, a Bcl-2 antagonist, plus topotecan in solid tumor malignancies
    Journal Article

    Paik, P. K.; Rudin, C. M.; Brown, A.; Rizvi, N. A.; Takebe, N.; Travis, W.; James, L.; Ginsberg, M. S.; Juergens, R.; Markus, S.; more...
    Cancer Chemotherapy and Pharmacology (2010)

    Fulltext@MSK | Save
  • Phase II trial of sunitinib in patients with relapsed or refractory germ cell tumors
    Journal Article

    Feldman, D. R.; Turkula, S.; Ginsberg, M. S.; Ishill, N.; Patil, S.; Carousso, M.; Bosl, G. J.; Motzer, R. J.
    Investigational New Drugs (2010)

    Fulltext@MSK | Save
  • A phase I clinical trial of FOLFIRI in combination with the pan-cyclin-dependent kinase (CDK) inhibitor flavopiridol
    Journal Article

    Dickson, M. A.; Shah, M. A.; Rathkopf, D.; Tse, A.; Carvajal, R. D.; Wu, N.; Lefkowitz, R. A.; Gonen, M.; Cane, L. M.; Dials, H. J.; more...
    Cancer Chemotherapy and Pharmacology (2010)

    Fulltext@MSK | Save
  • Interactive dedicated training curriculum improves accuracy in the interpretation of MR imaging of prostate cancer
    Journal Article

    Akin, O.; Riedl, C. C.; Ishill, N. M.; Moskowitz, C. S.; Zhang, J.; Hricak, H.
    European Radiology (2010)

    Fulltext@MSK | Save
  • Disorders of bone marrow
    Conference Paper

    Karantanas, A. H.; Panicek, D. M.
    Springer (2009)

    Fulltext@MSK | Save
  • Renal oncocytosis: Imaging considerations
    Journal Article

    Ariaratnam, N.; Riedl, C.; Tickoo, S.; Russo, P.; Rademaker, J.; Zhang, J.
    Abdominal Imaging (2009)

    Fulltext@MSK | Save
  • Phase II trial of lenalidomide in patients with metastatic renal cell carcinoma
    Journal Article

    Patel, P. H.; Kondagunta, G. V.; Schwartz, L.; Ishill, N.; Bacik, J.; Deluca, J.; Russo, P.; Motzer, R. J.
    Investigational New Drugs (2008)

    Fulltext@MSK | Save
  • Phase II trial of sequential paclitaxel and 1 h infusion of bryostatin-1 in patients with advanced esophageal cancer
    Journal Article

    Ku, G. Y.; Ilson, D. H.; Schwartz, L. H.; Capanu, M.; O'reilly, E.; Shah, M. A.; Kelsen, D. P.; Schwartz, G. K.
    Cancer Chemotherapy and Pharmacology (2008)

    Fulltext@MSK | Save
  • Pneumatosis intestinalis: A variant of bevacizumab related perforation possibly associated with chemotherapy related GI toxicity
    Journal Article

    Asmis, T. R.; Chung, K. Y.; Teitcher, J. B.; Kelsen, D. P.; Shah, M. A.
    Investigational New Drugs (2008)

    Fulltext@MSK | Save
  • Tanespimycin (an Hsp90 inhibitor) and trastuzumab is an active combination in patients (pts) with Her2-positive trastuzumab-refractory metastatic breast cancer (MBC): Phase 2 trial
    Meeting Abstract

    Modi, S.; Stopeck, A.; Kinden, H.; Sugarman, S.; Ma, W.; Solit, D.; Kersey, K.; Johnson, R.; Hannah, A. L.; Hudis, C.
    Breast Cancer Research and Treatment (2007)

    Fulltext@MSK | Save